Blake Marggraff graduated from Washington University in May, 2015 and founded the digital health company Epharmix, based on research around chronic disease management for medically underserved patient populations. Epharmix has demonstrated meaning clinical outcomes for several major chronic conditions and has received recognition including the WUSTL Global Impact Award in 2016. Epharmix investors include HealthX Ventures, Nobel laureate and Biogen founder Dr. Wally Gilbert, XPRIZE Founder Peter Diamandis, MD, and Yahoo! and Google founding team members. Prior to founding Epharmix, Blake co-founded the education technology company Betabox Labs, scaling to dozens of universities across the U.S. Blake’s passion for both technology and research originated during his work in nuclear medicine, one part of which was awarded the top prize at Intel’s 2011 International Science and Engineering Fair.
